Clinical Trials List
2023-08-01 - 2032-06-30
Phase III
Recruiting7
ICD-10C83.30
Diffuse large B-cell lymphoma, unspecified site
ICD-10C83.39
Diffuse large B-cell lymphoma, extranodal and solid organ sites
ICD-10C84.60
Anaplastic large cell lymphoma, ALK-positive, unspecified site
ICD-10C84.69
Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites
ICD-10C84.70
Anaplastic large cell lymphoma, ALK-negative, unspecified site
ICD-10C84.79
Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites
ICD-10C85.20
Mediastinal (thymic) large B-cell lymphoma, unspecified site
ICD-10C85.21
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck
ICD-10C85.22
Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes
ICD-10C85.23
Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes
ICD-10C85.24
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb
ICD-10C85.25
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb
ICD-10C85.26
Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes
ICD-10C85.27
Mediastinal (thymic) large B-cell lymphoma, spleen
ICD-10C85.28
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites
ICD-10C85.29
Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites
ICD-10C96.4
Sarcoma of dendritic cells (accessory cells)
ICD-10C96.5
Multifocal and unisystemic Langerhans-cell histiocytosis
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9200.00
Reticulosarcoma, unspecified site, extranodal solid organ sites
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shang-Ju Wu 無
- Tai-Chung Huang 無
- YAO CHI-YUAN 無
- 劉高郎 無
- Chien-Chin Lin 無
- 田豐銘 無
- Wen-Chien Chou 無
- Huai-Hsuan Huang 無
- Chieh-Lung Cheng 無
- 林明恩 無
- 柯紀綸 無
- - - 無
- Chien-Yuan Chen 無
- HSIN-AN HOU 無
- MING YAO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin 無
- Yu-Min Liao 無
- Chi-Ching Chen 無
- Tzu-Ting Chen 無
- 王秀慈 無
- 王幸婷 無
- Ming-Yu Lien 無
- 鄭富銘 無
- Wei-Ching Lin 無
- Ching-Chan Lin 無
- Ching Yun Hsieh 無
- 陳珈妤 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
1130 participants
